FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Timo Joensuu

Research Profile

Procedures

Living Beings

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Virus Replication

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Anna Kanerva; Lotta Kangasniemi; Antti Koski; Leena Laasonen; Ilkka Liikanen; Petri Nokisalmi; Minna Oksanen; Kaarina Partanen; Sari Pesonen; Saila Pesonen; Siri Tähtinen; Tuomo Alanko; Vincenzo Cerullo; Iulia Diaconu; Raita Heiskanen; Timo Joensuu; Kalevi Kairemo; Akseli Hemminki
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus.
Pirkko Kellokumpu-Lehtinen; Fredrik Laestadius; Ilari Lehtinen; Marjaana Luukkaa; Tiina Luukkaala; John McCaffrey; Ray McDermott; Sten Nilsson; Paul Nyandoto; Katinka Sandberg; Tiina Tasmuth; Taina Turpeenniemi-Hujanen; Raija Asola; Claes Ginman; Ulrika Harmenberg; Akseli Hemminki; Petteri Hervonen; Heikki Joensuu; Timo Joensuu; Maccon Keane
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
Otto Hemminki; Timo Joensuu; Kalevi Kairemo; Anna Kanerva; Lotta Kangasniemi; Leena Laasonen; Andre Lieber; Kaarina Partanen; Sari Pesonen; Saila K Pesonen; Vincenzo Cerullo; Iulia Diaconu; Akseli Hemminki
Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Timo Joensuu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Kanerva; Lotta Kangasniemi; Antti Koski; Leena Laasonen; Ilkka Liikanen; Petri Nokisalmi; Minna Oksanen; Kaarina Partanen; Sari Pesonen; Saila Pesonen; Siri Tähtinen; Tuomo Alanko; Vincenzo Cerullo; Iulia Diaconu; Raita Heiskanen; Timo Joensuu; Kalevi Kairemo; Akseli Hemminki
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(10):2734-44.
2013: Pirkko Kellokumpu-Lehtinen; Fredrik Laestadius; Ilari Lehtinen; Marjaana Luukkaa; Tiina Luukkaala; John McCaffrey; Ray McDermott; Sten Nilsson; Paul Nyandoto; Katinka Sandberg; Tiina Tasmuth; Taina Turpeenniemi-Hujanen; Raija Asola; Claes Ginman; Ulrika Harmenberg; Akseli Hemminki; Petteri Hervonen; Heikki Joensuu; Timo Joensuu; Maccon Keane
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
The lancet oncology 2013;14(2):117-24.
2012: Otto Hemminki; Timo Joensuu; Kalevi Kairemo; Anna Kanerva; Lotta Kangasniemi; Leena Laasonen; Andre Lieber; Kaarina Partanen; Sari Pesonen; Saila K Pesonen; Vincenzo Cerullo; Iulia Diaconu; Akseli Hemminki
Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2012;20(9):1821-30.
2012: Sari Pesonen; Mari Raki; Vincenzo Cerullo; Iulia Diaconu; Gianpietro Dotti; Sophie Escutenaire; Kilian Guse; Elina Haavisto; Päivi Hannuksela; Sirkka-Liisa Holm; Timo Joensuu; Anna Kanerva; Lotta Kangasniemi; Aila Karioja-Kallio; Eerika Karli; Satu Kauppinen; Leena Laasonen; Petri Nokisalmi; Minna Oksanen; Kaarina Partanen; Akseli Hemminki
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.
International journal of cancer. Journal international du cancer 2012;130(8):1937-47.
2012: Sari Pesonen; Saila K Pesonen; Tuuli Ranki; Tuomo Alanko; Vincenzo Cerullo; Iulia Diaconu; Ulrike Gerdemann; Elina Haavisto; Sirkka-Liisa Holm; Timo Joensuu; Kalevi Kairemo; Anna Kanerva; Lotta Kangasniemi; Aila Karioja-Kallio; Satu Kauppinen; Leena Laasonen; Ann Leen; Minna Oksanen; Kaarina P L Partanen; Akseli Hemminki
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients.
Cancer research 2012;72(7):1621-31.
2011: Vincenzo Cerullo; Iulia Diaconu; Sophie Escutenaire; Elina Haavisto; Petteri T Arstila; Sirkka-Liisa Holm; Timo Joensuu; Anna Kanerva; Lotta Kangasniemi; Aila Karioja-Kallio; Satu Kauppinen; Antti Koski; Leena Laasonen; Minna Oksanen; Kaarina Partanen; Sari Pesonen; Maria Rajecki; Valentina Romano; Noora Rouvinen; Tamara Tuuminen; Akseli Hemminki
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(9):1737-46.
2011: Mari Raki; Merja Sarkioja; Vincenzo Cerullo; Sophie Escutenaire; Elina Haavisto; Timo Joensuu; Anna Kanerva; Lotta Kangasniemi; Minna Oksanen; Sari Pesonen; Akseli Hemminki
Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients.
The journal of gene medicine 2011;13(5):253-61.
2011: Maria Rajecki; Aki Kangasmäki; Leena Laasonen; Sophie Escutenaire; Tanja Hakkarainen; Jarmo Haukka; Ari Ristimäki; Kalevi Kairemo; Lotta Kangasniemi; Timo Kiljunen; Timo Joensuu; Sari Pesonen; Akseli Hemminki
Sodium iodide symporter SPECT imaging of a patient treated with oncolytic adenovirus Ad5/3-Δ24-hNIS.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(4):629-31.
2011: Sophie Escutenaire; Vincenzo Cerullo; Iulia Diaconu; Laura Ahtiainen; Päivi Hannuksela; Minna Oksanen; Elina Haavisto; Aila Karioja-Kallio; Sirkka-Liisa Holm; Lotta Kangasniemi; Camilla Ribacka; Satu Kauppinen; Timo Joensuu; T Petteri Arstila; Sari Pesonen; Anna Kanerva; Akseli Hemminki
In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments.
Annals of medicine 2011;43(2):151-63.
2011: Maria Rajecki; Mari Raki; Sophie Escutenaire; Sari Pesonen; Vincenzo Cerullo; Andreas Helminen; Päivi Hannuksela; Kaarina Partanen; Leena Laasonen; Timo Joensuu; Lotta Kangasniemi; Elina Haavisto; Anna Kanerva; Laura Ahtiainen; Akseli Hemminki
Safety of glucocorticoids in cancer patients treated with oncolytic adenoviruses.
Molecular pharmaceutics 2011;8(1):93-103.
2010: Anniina Koski; Lotta Kangasniemi; Sophie Escutenaire; Sari Pesonen; Vincenzo Cerullo; Iulia Diaconu; Petri Nokisalmi; Mari Raki; Maria Rajecki; Kilian Guse; Tuuli Ranki; Minna Oksanen; Sirkka-Liisa Holm; Elina Haavisto; Aila Karioja-Kallio; Leena Laasonen; Kaarina Partanen; Matteo Ugolini; Andreas Helminen; Eerika Karli; Päivi Hannuksela; Saila Pesonen; Timo Joensuu; Anna Kanerva; Akseli Hemminki
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.
Molecular therapy : the journal of the American Society of Gene Therapy 2010;18(10):1874-84.
2010: Greetta Joensuu; Timo Joensuu; Petri Nokisalmi; Chandana Reddy; Jorma Isola; Mirja Ruutu; Mauri Kouri; Patrick A Kupelian; Juhani Collan; Sari Pesonen; Akseli Hemminki
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer.
International journal of radiation oncology, biology, physics 2010;78(1):42-9.
2010: S Pesonen; P Nokisalmi; Sophie Escutenaire; Merja Särkioja; Mari Raki; Vincenzo Cerullo; Lotta Kangasniemi; Leena Laasonen; Camilla Ribacka; Kilian Guse; E Haavisto; M Oksanen; Maria Rajecki; A Helminen; Ari Ristimäki; A Karioja-Kallio; E Karli; T Kantola; Gerd J Bauerschmitz; Anna Kanerva; Timo Joensuu; Akseli Hemminki
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors.
Gene therapy 2010;17(7):892-904.
2010: Petri Nokisalmi; Sari Pesonen; Sophie Escutenaire; Merja Särkioja; Mari Raki; Vincenzo Cerullo; Leena Laasonen; Ramon Alemany; Juan Rojas; Manel Cascallo; Kilian Guse; Maria Rajecki; Lotta Kangasniemi; Elina Haavisto; Aila Karioja-Kallio; Päivi Hannuksela; Minna Oksanen; Anna Kanerva; Timo Joensuu; Laura Ahtiainen; Akseli Hemminki
Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(11):3035-43.
2010: Vincenzo Cerullo; Sari Pesonen; Iulia Diaconu; Sophie Escutenaire; Petteri T Arstila; Matteo Ugolini; Petri Nokisalmi; Mari Raki; Leena Laasonen; Merja Särkioja; Maria Rajecki; Lotta Kangasniemi; Kilian Guse; Andreas Helminen; Laura Ahtiainen; Ari Ristimäki; Anne Räisänen-Sokolowski; Elina Haavisto; Minna Oksanen; Eerika Karli; Aila Karioja-Kallio; Sirkka-Liisa Holm; Mauri Kouri; Timo Joensuu; Anna Kanerva; Akseli Hemminki
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients.
Cancer research 2010;70(11):4297-309.
2010: Sari Pesonen; Heikki Helin; Petri Nokisalmi; Sophie Escutenaire; Camilla Ribacka; Merja Sarkioja; Vincenzo Cerullo; Kilian Guse; Gerd Bauerschmitz; Leena Laasonen; T Kantola; Ari Ristimaki; Maria Rajecki; Minna Oksanen; Elina Haavisto; Anna Kanerva; Timo Joensuu; Akseli Hemminki
Oncolytic adenovirus treatment of a patient with refractory neuroblastoma.
Acta oncologica (Stockholm, Sweden) 2010;49(1):117-9.
2007: Pälvi Vento; Harri Mustonen; Timo Joensuu; Päivi Kärkkäinen; Eero Kivilaakso; Tuula Kiviluoto
Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer.
World journal of gastroenterology : WJG 2007;13(21):2945-51.
2007: Antti A Mäkitie; Petri Koivunen; Harri Keski-Säntti; Jyrki Törnwall; Matti Pukkila; Jussi Laranne; Marjaana Luukkaa; Jyrki Vuola; Timo Joensuu; Mikael Kajanti; Reidar Grénman
Oral tongue carcinoma and its treatment in Finland.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2007;264(3):263-7.
2004: Timo Joensuu; S Nilsson; A R Holmberg; M Márquez; Mikko Tenhunen; Tiina Saarto; Heikki Joensuu
Phase I trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer.
Annals of the New York Academy of Sciences 2004;1028():361-74.
2004: Timo Joensuu; Tuula Kiviluoto; Päivi Kärkkäinen; Pälvi Vento; Leena Kivisaari; Mikko Tenhunen; Ronny Westberg; Inkeri Elomaa
Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2004;60(2):444-52.
2003: Tero Kivelä; Mikko Tenhunen; Timo Joensuu; Petri Tommila; Heikki Joensuu; Mauri Kouri
Stereotactic radiotherapy of symptomatic circumscribed choroidal hemangiomas.
Ophthalmology 2003;110(10):1977-82.
2002: Kauko Saarilahti; Mikael Kajanti; Timo Joensuu; Mauri Kouri; Heikki Joensuu
Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
International journal of radiation oncology, biology, physics 2002;54(2):479-85.